Clinical Trials Sponsored by Kyorin University

Total 223796 results

Kyowa Kirin Co., Ltd.

Completed

PK, Tolerability and Safety of the Co-administration of Sancuso® (Transdermal Granisetron) and IV Granisetron

Healthy

United Kingdom
Kyowa Kirin Co., Ltd.

Completed

Dose-finding Study of KHK7791 in Hyperphosphatemia Patients

Hyperphosphatemia

Japan
Kyowa Kirin Co., Ltd.

Completed

A Phase 3 Clinical Study of KHK 4827

Psoriasis Vulgaris | Psoriatic Arthritis | Pustular; Psoriasis, Palmaris Et Plantaris | Psoriatic Erythroderma

Japan
Kyowa Kirin Co., Ltd.

Completed

Observational Study for Non-motor Symptoms and Treatment in Parkinson's Disease Patients (J-FIRST)

Parkinson Disease

Japan
Kyowa Kirin Co., Ltd.

Terminated

A Safety Study of KHK4951 in Healthy Volunteers and Patients With Wet Age-Related Macular Degeneration

Healthy Volunteers | Wet Age-related Macular Degeneration

Japan
Kyowa Kirin Co., Ltd.

Active, not recruiting

Study to Assess the Safety, Pharmacokinetics and Efficacy of KRN23 in Adult Chinese Patients With XLH

X-linked Hypophosphatemia (XLH)

China
Kyowa Kirin Co., Ltd.

Active, not recruiting

Study to Assess the Safety, Pharmacokinetics and Efficacy of KRN23 in Adult Chinese Patients With TIO

Tumor-Induced Osteomalacia (TIO)

China
Kyowa Kirin Co., Ltd.

Completed

A Study of KRN125 in Patients With Multiple Myeloma and Malignant Lymphoma

Multiple Myeloma and Malignant Lymphoma

Japan
Kyowa Kirin Co., Ltd.

Active, not recruiting

A Phase 3 Study of KHK4827 in Patients With Systemic Sclerosis

Moderate to Severe Systemic Sclerosis

Japan
Kyowa Kirin Co., Ltd.

Active, not recruiting

A Study of KHK4827 in Patients With Systemic Sclerosis

Systemic Sclerosis

Japan
Kyowa Kirin Co., Ltd.

Completed

A Study of KRN23 in Pediatric Patients With X-linked Hypophosphatemic Rickets/Osteomalacia

X-linked Hypophosphatemic Rickets/Osteomalacia

Japan
Kyowa Kirin Co., Ltd.

Completed

A Study of KRN23 in Subjects With Tumor-Induced Osteomalacia or Epidermal Nevus Syndrome

Tumor-Induced Osteomalacia or Epidermal Nevus Syndrome

Japan, Korea, Republic of
Kyowa Kirin Co., Ltd.

Completed

A Study of KRN23 in Adult and Pediatric Patients With X-linked Hypophosphatemic Rickets/Osteomalacia

XLH

Japan, Korea, Republic of
Kyowa Kirin Co., Ltd.

Completed

Study of Romiplostim(AMG531) in Subjects With Aplastic Anemia

Aplastic Anemia

Japan, Korea, Republic of
Kyowa Kirin Co., Ltd.

Completed

Phosphate Binder-combination Study of KHK7791 in Hyperphosphatemia Patients on Hemodialysis

Hyperphosphatemia

Japan
Kyowa Kirin Co., Ltd.

Completed

A Through QT/QTc Study of KW-6356

Parkinson's Disease

Japan
Kyowa Kirin Co., Ltd.

Completed

A Study of KHK4827 in Subjects With Axial Spondyloarthritis (axSpA)

Axial Spondyloarthritis

Korea, Republic of, Taiwan, Japan
Kyowa Kirin Co., Ltd.

Completed

A Phase 4 Clinical Study of Brodalumab

Psoriasis Vulgaris | Psoriatic Arthritis | Pustular; Psoriasis, Palmaris Et Plantaris | Psoriatic Erythroderma

Japan
Kyowa Kirin Farmacéutica S.L.U.

Completed

Evaluation of the Quality of Life of Patients With Opioid-induced Constipation Under Treatment With Naloxegol (KYONAL)

Opioid-induced Constipation

Spain
MicroPort CRM
Sorin CRM

Unknown

Clinical Trial of the SonRtip Lead and Automatic AV-VV Optimization Algorithm in the PARADYM RF SonR CRT-D (RESPOND-CRT)

Heart Failure NYHA Class III and Ambulatory IV

United States, Spain, United Kingdom, Germany, Italy, Australia, Netherlands, Portugal, France, Austria, Switzerland, Slovenia
MicroPort CRM
Sorin CRM

Unknown

Continued Access Clinical Trial of the SonRtip Lead and Automatic AV-VV Optimization Algorithm in the PARADYM RF SonR CRT-D (RESPOND-CAS)

Heart Failure (NYHA Class III and Ambulatory IV)

United States
Kyowa Kirin Co., Ltd.

Completed

Phase 2 Study of KHK4577

Atopic Dermatitis

Japan
Kyowa Kirin Co., Ltd.

Completed

A Phase 1 Study of KHK4083 in Subjects With Atopic Dermatitis

Dermatitis, Atopic

Japan
Kyowa Kirin Co., Ltd.

Completed

The Phase II Study of Bardoxolone Methyl in Patients With Chronic Kidney Disease and Type 2 Diabetes; TSUBAKI Study

Type 2 Diabetes | Chronic Kidney Disease

Japan
Kyowa Kirin Co., Ltd.

Completed

A Randomized Double-blind, Placebo-controlled Japanese Phase III Trial of ARQ 197 in Hepatocellular Carcinoma (HCC) (JET-HCC)

Liver Cancer

Japan
Kyowa Kirin Co., Ltd.

Completed

Phase 3 Study of KHK7580

Secondary Hyperparathyroidism

Japan
Kyowa Kirin Co., Ltd.

Terminated

Phase 1 Study of KHK2898 in Subjects With Advanced Solid Tumors

Solid Tumour

Singapore
Kyowa Kirin Co., Ltd.

Completed

A Clinical Pharmacology Study of Saxagliptin in Patients With Type 2 Diabetes Mellitus

Diabetes

Japan
Kyowa Kirin Co., Ltd.

Completed

Study of KW-0761 in Subjects With CCR4-positive Peripheral T/NK-cell Lymphoma

Peripheral T/NK-cell Lymphoma

Japan
Kyowa Kirin Co., Ltd.

Completed

Placebo-Controlled Double-Blind Crossover Comparative Study of KW-6500 (6500-004)

Parkinson's Disease

Japan
Kyowa Kirin Co., Ltd.

Completed

A Study of KRN23 in Subjects With X-linked Hypophosphatemic Rickets/Osteomalacia

X-linked Hypophosphatemic Rickets/Osteomalacia

Japan, Korea, Republic of
Kyowa Kirin Co., Ltd.

Completed

Phase 1/2 Study of KHK7580 for Secondary Hyperparathyroidism in Patients Receiving Hemodialysis

Hyperparathyroidism

Japan
Kyowa Kirin Co., Ltd.

Completed

Study of KRN951 in Patients With Solid Tumors

Solid Tumors

Japan
Kyowa Kirin Co., Ltd.

Completed

Study of KHK7580 for Secondary Hyperparathyroidism in Patients Receiving Peritoneal Dialysis

Secondary Hyperparathyroidism

Japan
Kyowa Kirin Co., Ltd.

Completed

A Phase 3 Clinical Study of KHK4827

Psoriasis

Japan
Sorin Group USA, Inc.

Completed

Safety and Efficacy Study of the Sorin 3D Annuloplasty Ring For Mitral Repair (MEMO3D)

Mitral Valve Regurgitation

United States, Canada
Kyowa Kirin Co., Ltd.

Completed

A Study of Istradefylline (KW-6002) for the Treatment of Parkinson's Disease in Patients Taking Levodopa

Parkinson's Disease

Japan
Kyowa Kirin Co., Ltd.

Completed

A Study of OPC-262 in Patients With Type 2 Diabetes

Diabetes Type 2

Japan
Kyowa Kirin Co., Ltd.

Completed

Along-term Study of OPC-262 in Patients With Type 2 Diabetes

Diabetes, Type 2

Japan
Kyowa Kirin Co., Ltd.

Completed

A Study of OPC-262 in Patients With Type 2 Diabetes

Type 2 Diabetes

Japan
Kyowa Kirin Co., Ltd.

Completed

A Phase 1 Study of ARQ 197 in Patients With Solid Tumors

Cancer
Kyowa Kirin Co., Ltd.

Completed

Clinical Study of KW-2246 in Patients With Cancer Pain

Pain | Cancer

Japan
Kyowa Kirin Co., Ltd.

Completed

A Dose Finding Study of KRN321(Darbepoetin Alfa) for the Treatment of Anemia in Subjects With Solid Tumor

Anemia

Japan
Kyowa Kirin Co., Ltd.

Completed

A Phase 2b Study of Istradefylline (KW-6002) for the Treatment of Parkinson's Disease in Patients Taking Levodopa

Parkinson's Disease

Japan
Kyowa Kirin Co., Ltd.

Completed

Study of KW-6002 (Istradefylline) for the Treatment of Parkinson's Disease in Patients Taking Levodopa (6002-009)

Parkinson's Disease

Japan
Kyowa Kirin Co., Ltd.

Completed

Mineral and Bone Disorders Outcomes in Stage 5D of Chronic Kidney Disease (MBD-5D)

End Stage Renal Disease | Hyperparathyroidism, Secondary

Japan
Sorin Group USA, Inc.

Terminated

CarboMedics Top Hat vs St. Jude Medical Regent Valve Comparing Sizing and Hemodynamics

Aortic Valve Disease

United States
Sorin Group USA, Inc.

Completed

Clinical Investigation Of The Mitroflow Aortic Pericardial Heart Valve

Heart Valve Diseases

United States, Canada
Kyowa Kirin Co., Ltd.
Kyowa Hakko Kirin Pharma, Inc.; Teva Pharma

Completed

Phase 1 Study of CEP-37250/KHK2804 in Subjects With Advanced Solid Tumors

Adenocarcinoma of the Pancreas | Solid Tumour | Adenocarcinoma of the Colorectal
Kyowa Kirin Co., Ltd.
Kyowa Hakko Kirin China Pharmaceutical Co., LTD.

Withdrawn

A Phase 4 Study of Brodalumab (KHK4827) in Subjects With Moderate to Severe Plaque Psoriasis

Moderate to Severe Plaque Psoriasis

China

Clinical Trials Sponsored by Kyorin University

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Romania

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations